| Weill Cornell Physician-Scientists Present Latest Cancer Findings At ...
Leading hematologists at NewYork-Presbyterian Hospital/Weill Cornell Medical Center are presenting new basic and clinical research findings at the 46th annual American Society of Hematology (ASH) meeting in Atlanta, Dec. 8-11.
Among the presenters, Dr. Andrew I. Schafer, president of ASH, chairman of the Department of Medicine and E. Hugh Luckey Distinguished Professor of Medicine at Weill Cornell Medical College, and physician-in-chief at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, will be chairing and co-chairing several special lectures (see below).
Highlights from the 45 symposium presentations and posters to be made by NewYork-Presbyterian/Weill Cornell physician-scientists include the following:
* New Drug Dramatically Improves ITP Blood Disorder [568]
Simultaneous Session: Novel Therapy for ITP
Monday, December 10, 1:30 p.m.
ICRC says Israeli clamps worsen Gaza and W.Bank crisis
As a result of the West Bank Barrier, built inside Palestinian territory, it said "large tracts of farming land have been out of reach for farmers," who must fight through "a bureaucratic maze" to get permits needed to reach their fields. Many applications are rejected on security grounds, which "may include a relative once having been in an Israeli prison." The ICRC depends on its neutrality to distribute emergency aid and help victims of conflict and violence around the world. It stressed that while Israel has the right to protect its population, "there should always be a sound balance between Israel's security concerns and the protection of the rights and liberties of the Palestinians living under occupation." "So far, the balance between the legitimate Israeli security concerns and the right of the Palestinian people to live a normal life has not been struck," it said.
Freezing the Pain of Cancerous Tumors
In a study of 34 cancer patients, the method, called cryoablation, alleviated relentless pain that hadn't respond to all other treatments. "This was really severe, persistent pain that required patients to take narcotics just to get through the day," says researcher Matthew Callstrom, MD, PhD, a radiologist at the Mayo Clinic in Rochester, Minn. All reported at least some pain relief. All were able to cut back on, and in some cases even stop taking, narcotics. Most importantly, Callstrom tells WebMD, was the improvement in their quality of life. "Patients said, on average, that half their life was affected by pain at the start of the study. By 24 weeks later, it was down to 10%," he says. The findings were presented at the annual meeting of the Radiological Society of North America.
|
